Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:11 pm Sale | 2024-02-22 | 13G | Lexaria Bioscience Corp. LEXX | Invenomic Capital Management LP | 567,650 4.700% | -164,331 (-22.45%) | Filing History |
| 2024-02-14 12:00 pm Purchase | 2023-12-31 | 13G | Lexaria Bioscience Corp. LEXX | Invenomic Capital Management LP | 731,981 7.120% | 258,878 (+54.72%) | Filing History |
| 2024-02-14 12:00 pm Sale | 2023-12-31 | 13G | Unifi, Inc. UFI | Invenomic Capital Management LP | 813,753 4.490% | -130,537 (-13.82%) | Filing History |
| 2024-02-14 12:00 pm Sale | 2023-12-31 | 13G | Viant Technology Inc. DSP | Invenomic Capital Management LP | 439,371 2.830% | -364,019 (-45.31%) | Filing History |
| 2023-02-10 4:26 pm Purchase | 2022-12-31 | 13G | Unifi, Inc. UFI | Invenomic Capital Management LP | 944,290 5.240% | 944,290 (New Position) | Filing History |
| 2023-02-10 4:17 pm Purchase | 2022-12-31 | 13G | Viant Technology Inc. DSP | Invenomic Capital Management LP | 803,390 5.640% | 803,390 (New Position) | Filing History |
| 2023-02-10 4:06 pm Purchase | 2022-12-31 | 13G | Lexaria Bioscience Corp. LEXX | Invenomic Capital Management LP | 473,103 7.950% | 113,990 (+31.74%) | Filing History |
| 2022-03-10 4:00 pm Sale | 2022-02-28 | 13G | Immersion Corporation IMMR | Invenomic Capital Management LP | 1,669,161 4.980% | -29,394 (-1.73%) | Filing History |
| 2022-02-11 5:46 pm Purchase | 2021-12-31 | 13G | Immersion Corporation IMMR | Invenomic Capital Management LP | 1,698,555 5.140% | 1,698,555 (New Position) | Filing History |
| 2022-02-11 5:33 pm Purchase | 2021-12-31 | 13G | Lexaria Bioscience Corp. LEXX | Invenomic Capital Management LP | 359,113 6.030% | 359,113 (New Position) | Filing History |